Polomar Health Services PMHS
OTC PMHS
$0.20 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Polomar Health Services (PMHS) Non-Current Assets (2023 - 2026)

Polomar Health Services (PMHS) posted Non-Current Assets of $33476.0 for Q2 2026, down 31.61% on a QoQ basis from $48950.0 in Q1 2026, and down 99.64% year-over-year from $9.3 million in Q2 2025.

Analysis

Polomar Health Services (PMHS) Non-Current Assets (2023 - 2026) Analysis & Trends

Polomar Health Services has reported Non-Current Assets for 4 years, with the latest figure at $33476.0 in Q2 2026.

  • On a quarterly basis, Non-Current Assets fell 99.64% year-over-year to $33476.0 in Q2 2026; TTM through Jun 2026 was $9.2 million, a 76.33% decrease from a year earlier, with the FY2025 full-year figure at $67316.0, down 99.32% from the prior year.
  • Non-Current Assets was $33476.0 for Q2 2026 at Polomar Health Services, down from $48950.0 in the prior quarter.
  • The five-year high for Non-Current Assets was $10.1 million in Q3 2024, with the low at $33476.0 in Q2 2026.
  • Average Non-Current Assets over 4 years is $5.4 million, with a median of $9.1 million recorded in 2025.
  • The sharpest annual moves came in 2024 and 2026: Non-Current Assets jumped 10313.11% in 2024, then tumbled 99.64% in 2026.
  • Over 4 years, Non-Current Assets stood at $94832.0 in 2023, then surged by 10313.11% to $9.9 million in 2024, then sank by 99.32% to $67316.0 in 2025, then slumped by 50.27% to $33476.0 in 2026.
  • The last three Non-Current Assets figures came in at $33476.0 (Q2 2026), $48950.0 (Q1 2026), and $67316.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 26.10 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 24.99 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 2.92 Bn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 1.83 Bn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 18.27 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 1.04 Bn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 668.68 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 1.11 Bn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 3.25 Mn
10 Polomar Health Services 5.66 Mn 5.48 Mn 935,916.00 33,476.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33,476.00
Mar 31, 2026 48,950.00
Dec 31, 2025 67,316.00
Sep 30, 2025 9.07 Mn
Jun 30, 2025 9.34 Mn
Mar 31, 2025 9.61 Mn
Dec 31, 2024 9.87 Mn
Sep 30, 2024 10.14 Mn
Dec 31, 2023 94,832.00